By Stamford Health's Bennett Cancer Center and Breast Center Staff
With many breast cancer chemotherapies, hair loss is inevitable. For women especially, this side effect can be both devastating and frustrating. To prevent hair loss, many women have tried different “cold caps,” which must be continuously chilled in special freezers or with dry ice in infusion centers, all logistics handled by the patient. Unfortunately, comfort and convenience were not factors. Until now.
Please note: there are out-of-pocket costs associated with this product that are paid directly to Dignitana, Inc.
Information Adapted from www.dignicap.com
With many breast cancer chemotherapies, hair loss is inevitable. For women especially, this side effect can be both devastating and frustrating. To prevent hair loss, many women have tried different “cold caps,” which must be continuously chilled in special freezers or with dry ice in infusion centers, all logistics handled by the patient. Unfortunately, comfort and convenience were not factors. Until now.The breakthrough DigniCap® scalp cooling system, offered at Stamford Health’s Bennett Cancer Center, is the first scalp cooling system to achieve FDA clearance from the United States for women diagnosed with breast cancer and on certain chemotherapy regimens. It’s a revolutionary alternative designed for comfort, convenience, and confidence in breast cancer patients with chemotherapy-related alopecia. Some of the many key features include:
- Availability in multiple sizes for a personalized fit
- Front and rear temperature management for consistent cooling of entire scalp
- Built-in security sensor to ensure scalp temperature stays above 32 degrees Fahrenheit
Please note: there are out-of-pocket costs associated with this product that are paid directly to Dignitana, Inc.
Information Adapted from www.dignicap.com
